Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.04M Buy
7,799
+252
+3% +$64.6K 0.86% 24
2026
Q2
$1.9M Buy
7,547
+171
+2% +$36.8K 0.86% 23
2026
Q1
$1.6M Sell
7,376
-436
-6% -$96.7K 0.9% 21
2025
Q4
$1.78M Buy
+7,812
New +$1.78M 1.1% 20

Other funds holding ABBV

EJMK Ventures's ABBV Position: Q3 2026 in Review

EJMK Ventures increased its AbbVie (ABBV) stake by 3.3% in Q3 2026, buying an estimated $64.6K and bringing the position to 7,799 shares worth $2.04M. The position accounts for 0.86% of the portfolio, ranked #24.

EJMK Ventures first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. 4,273 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • EJMK Ventures held 7,799 shares of AbbVie worth $2.04M as of Q3 2026.
  • EJMK Ventures bought 252 AbbVie shares in Q3 2026, an estimated $64.6K.
  • AbbVie made up 0.86% of EJMK Ventures's portfolio in Q3 2026, its #24 holding.
  • EJMK Ventures first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • 4,273 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on EJMK Ventures's 13F filing for Q3 2026, filed 21 Oct 2026.